Kaohsiung, Taiwan

Jei-Fu Shaw

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jei-Fu Shaw. Retrieved from https://idiyas.com/inventor/jei-fu-shaw-fqtcepr8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jei-Fu Shaw in Polyacetylene Compounds

Introduction: Jei-Fu Shaw is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of chemistry, particularly in the development of polyacetylene compounds. His work focuses on the extraction and application of these compounds for pharmaceutical purposes.

Latest Patents: Jei-Fu Shaw holds a patent for a polyacetylene compound, which is an extract containing the same and its applications. The patent describes a polyacetylene that is isolated from an extract of sporophores. This compound has been found to inhibit the production of nitric oxide, making it valuable for preparing pharmaceutical compositions aimed at anti-inflammation.

Career Highlights: Throughout his career, Jei-Fu Shaw has demonstrated a commitment to advancing scientific knowledge and practical applications in the field of chemistry. His innovative work has led to the development of new methods for utilizing natural extracts in medical applications.

Collaborations: Jei-Fu Shaw has collaborated with notable colleagues, including Sheng-Yang Wang and Ting-Yu Lin. These partnerships have contributed to the advancement of research and development in their respective fields.

Conclusion: Jei-Fu Shaw's contributions to the field of polyacetylene compounds highlight the importance of innovation in pharmaceutical applications. His work not only advances scientific understanding but also has the potential to improve health outcomes through new anti-inflammatory treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…